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Hydrogen sulfide (H2S) has emerged as a signalling molecule capable of regulating several important
physiological functions such as blood pressure, neurotransmission and inflammation. The mechanisms
behind these effects are still largely elusive and oxidative posttranslational modification of cysteine
residues (protein persulfidation or S-sulfhydration) has been proposed as the main pathway for H2S-
induced biological and pharmacological effects. As a signalling mechanism, persulfidation has to be
controlled. Using an improved tag-switch assay for persulfide detection we show here that protein
persulfide levels are controlled by the thioredoxin system. Recombinant thioredoxin showed an almost
10-fold higher reactivity towards cysteine persulfide than towards cystine and readily cleaved protein
persulfides as well. This reaction resulted in H2S release suggesting that thioredoxin could be an
important regulator of H2S levels from persulfide pools. Inhibition of the thioredoxin system caused an
increase in intracellular persulfides, highlighting thioredoxin as a major protein depersulfidase that
controls H2S signalling. Finally, using plasma from HIV-1 patients that have higher circulatory levels of
thioredoxin, we could prove depersulfidase role in vivo.Introduction
Oxidative posttranslational modications (oxPTM) of protein
cysteine residues are important for regulation of diverse cellular
functions.1 From S-nitrosation2,3 and S-glutathionylation4,5 to S-cy, Friedrich-Alexander University of
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tion (ESI) available. See DOI:sulfenylation,1,6 thesemodications have been linked to signalling
by reactive nitrogen and oxygen species. The recent emergence of
a new signalling molecule, hydrogen sulde (H2S), has provided
insights into another oxPTM of cysteine, persuldation (also
called S-sulydration).7–10 Thus far, persuldation of a handful of
proteins has been demonstrated to be important for the regulation
of blood pressure (KATP channel),11 cell senescence (Keap-1),12 and
cell apoptosis (GAPDH and NF-kB).7,13 Additionally persuldation
of parkin increased its activity, suggesting that pharmacological
H2S donors might be benecial for the treatment of Parkinson's
disease14 and possibly other neurodegenerative diseases.
Intracellular protein disulde and S-glutathionylation levels
are controlled by the thioredoxin (Trx) system.15–17 The enzy-
matic system, consisting of Trx, thioredoxin reductase (TrxR)
and NADPH, represents the main disulde reductase system in
cells. Trx also regulates S-nitrosation.18,19 Numerous studies
have shown that Trx acts as a denitrosylase and is also involved
in selective trans-nitrosation (i.e. the transfer of an “NO+”
moiety from an S-nitrosothiol to another cysteine residue).20–22
The latter is best illustrated by Trx-mediated caspase 3 S-nitro-
sation, which prevents apoptosis.20
To exert a regulatory function similar to that of phosphory-
lation/dephosphorylation or S-nitrosation/denitrosation, S-per-
suldation levels must be enzymatically regulated.9,10 Due to theThis journal is © The Royal Society of Chemistry 2016
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View Article Onlinemeta-stability of persuldes and their higher nucleophilicity
(and therefore reactivity) compared to thiols, it is challenging to
study their biochemistry. The lack of selective tools for labelling
persuldes additionally complicates these studies.23,24 We have
recently developed a tag-switch method for selective persulde
labelling25,26 and assessed alternative mechanisms for persul-
de formation, suggesting that persuldes could be formed
from sulfenylated cysteine residues.27 Some evidence already
exists to suggest that Trx can cleave persulde from the active
site of mercaptopyruvate sulfur transferase (MST) leading to
H2S release.28,29 To asses the global role of Trx system on protein
persuldation, we herein developed an improved tag-switch
assay and showed that the Trx system reacts approximately an
order of magnitude faster with persuldes than their disulde
analogs, and is the major regulator of protein persulde levels
in the cells.Fig. 1 Trx reacts with LMW persulfide NAP-SSH. (A) NAP-SSH undergoe
Kinetics of 50 mM NAP-SSH decay followed by MS. Disappearance of t
absence (black squares) and presence of 50 mMTrx (red circles), was plott
208.0638) peak, which corresponds to NAPSH, indicate that Trx cleav
Deconvoluted mass spectrum of [Trxred + H]
+ (black) and simulated isot
See Fig. S2 in ESI.† (E) Deconvoluted mass spectrum of Trx mixed with N
(C528H836N132O159S3; blue). See Fig. S2 in ESI.† (F) Overlay of the starting T
NAP-SSH clearly indicates m/z 2 leftward shift, indicative of the loss of 2
This journal is © The Royal Society of Chemistry 2016Results and discussion
To assess the potential role of Trx in persulde reduction, we
rst used the low molecular weight (LMW) persulde analogue
of S-nitrosopenicillamine (NAP-SSH)30 (Fig. 1A). NAP-SSH
spontaneously decomposes when added in the buffer, as some
of us demonstrated previously.30 The reaction was monitored by
time-resolved mass spectrometry. NAP-SSH is metastable and
its decay was monitored by the disappearance of the parent ion
peak (at m/z 240.0347; calculated 240.0359 Fig. 1B and S1 in
ESI†), and the appearance of peaks with m/z 208.0623 (calcu-
lated 208.0638) and 225.0883 (calculated 225.0904) corre-
sponding to [NAPSH + H]+ and [NAPSH + NH4]
+, respectively
(Fig. 1C and S1 in ESI†). The half-time for the spontaneous
decay of 50 mM NAP-SSH in ammonium carbonate buffer pH
7.38 was estimated to be 2.7  0.3 min and this is in good
agreement with previous chemical studies on its stability.30 Thes spontaneous re-arrangement in buffer to give persulfide analogs. (B)
he NAP-SSH parent ion (m/z 240.0347; calculated 240.0359), in the
ed over time. (C) Time resolvedMS spectra ofm/z 208.0623 (calculated
es NAP-SSH to form a thiol and release HS. See Fig. S1 in ESI.† (D)
opic distribution for the fully reduced Trx (C528H838N132O159S3; green).
AP-SSH (red) and simulated isotopic distribution of fully oxidized Trx
rx spectrum and the spectrum obtained after 2 min of incubation with
H atoms.
Chem. Sci., 2016, 7, 3414–3426 | 3415
Fig. 2 Trx system cleaves cysteine and protein persulfides to form H2S. (A) H2S release from 20 mM HSA-SSH upon addition of different
concentrations of Trx (E. coli), measured amperometrically by the H2S sensitive electrode. (B) Plot of the initial rates vs. the concentration of Trx.
(C) Combined with TrxR (rat) and NAPDH, Trx (human) efficiently release all sulfur trapped in HSA-SSH as H2S. Na2S was injected as internal
standard for the comparison. (D) Kinetic analysis of the reaction was performed by measuring the rates of NADPH oxidation varying the
concentration of HSA-SSH and keeping the concentrations of other parameters constant: 1 mM Trx (human), 0.01 mM TrxR (rat) and 250 mM
NADPH. Experiments were performed in triplicates. (E) Schematic overview of the reaction used for the generation of the CysSS/CysSSCys
mixture. (F) Kinetics of Trx (E. coli) oxidation (1 mM) with 10 mM CysSSCys (black line) or CysSS/CysSSCys mixture (red line), followed by tryp-
tophan fluorescence (lex 280 nm) changes. Inset: Emission spectra before and after the reaction of 1 mM Trx with 50 mM CysSS
/CysSSCys
mixture. See Fig. S5 in ESI.† (G) Kinetic analysis of the reaction of CysSSCys (black line) or CysSS/CysSSCys mixture (red line) with 1 mM Trx
(human), 0.01 mM TrxR (rat) and 250 mM NADPH.
3416 | Chem. Sci., 2016, 7, 3414–3426 This journal is © The Royal Society of Chemistry 2016
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Table 1 Kinetic parameters for the Trx/TrxR/NADPH-catalysed depersulfidase reaction. 1 mM Trx, 0.01 mM TrxR and 250 mM NADPH were used
for the reaction. Kinetic parameters for CysSS from the mixture of CysSS and CysSSCys were derived using the equation given by Pocklington
and Jeffery, 1969 (ref. 33)
Substrate Km (mM) Vmax (mM min
1) kcat/Km  105a (M1 min1) kcat/Km  107b (M1 min1) k1 x 103c (M1 min1)
HSA-SSH 17  3 2.4  0.2 1.4 1.4 246  48
CysSSCys 35  8 1.9  0.1 0.5 0.5 30  6
CysSSH 13  5 5.1  0.7 3.9 3.9 270  6
a Calculated based on [Trx] (human). b Calculated based on [TrxR] (rat). c k1 refers to the rate constant for the reaction between Trx and the substrate
in the absence of TrxR/NADPH.
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View Article Onlinepresence of equimolar Trx (E. coli) increased the decay of NAP-
SSH 10-fold (t1/2 ¼ 0.3  0.1 min). The mass spectrum of Trx
aer 2 min incubation with a 2-fold excess of NAP-SSH
showed the complete oxidation of Trx. The complete mass
spectra of reduced Trx and Trx treated with NAP-SSH are
shown in Fig. S2 in ESI,† and the isotopic distribution of the
observed and simulated reduced [Trxred + H]
+ and oxidized
[Trxox + H]
+ are shown in Fig. 1D and E, respectively. Complete
oxidation is demonstrated by the leward m/z 2 shi (Fig. 1F).
Two reaction mechanisms are possible to explain the reac-
tion: (i) transfer of the sulfane sulfur from NAP-SSH to the
nucleophilic cysteine of Trx leads to the transient formation
of Trx-SSH followed by the displacement of the sulde anion
by the resolving cysteine and formation of a disulde bond, or
(ii) a nucleophilic attack of one of the Trx cysteines to the
sulfane sulfur of NAP-SSH with immediate elimination of H2S
and formation of Trx-NAPSH disulde complex, followed by
the displacement of NAPSH by the resolving cysteine and
formation of a disulde bond. Either mechanism could result
in H2S generation. Therefore we examined H2S production
from 100 mM NAP-SSH treated with 10 mM Trx using an H2S-
selective electrode. While a H2S-specic current was not
detected with either Trx or NAP-SSH alone (the latter
decomposes spontaneously to give a mixture of tri, tetra and
pentasuldes of NAPSH),30 the addition of NAP-SSH to Trx-
containing buffer induced an immediate electrode response
(Fig. S3 in ESI†) indicative of H2S formation.
Although Trx showed activity towards LMW persuldes,
protein-bound persuldes are expected to represent a larger
sulfane sulfur pool. Therefore, we tested the reaction of Trx with
protein persuldes. We recently reported preparation of human
serum albumin persulde (HSA-SSH) and described its reac-
tivity.27 Addition of Trx (E. coli) to a solution containing 20 mM
HSA-SSH led to a concentration-dependent increase in the
initial rate of H2S production, as monitored by an H2S-sensitive
electrode (Fig. 2A), conrming our hypothesis that Trx reduces
protein persuldes in addition to LMW persuldes. Using an
initial rate approach, a second order rate constant for the
reaction of Trx with HSA-SSH was estimated to be 4.1  0.8 
103 M1 s1 (Fig. 2B). MS analysis of the reaction mixture con-
taining 20 mM Trx and 40 mM HSA-SSH revealed complete
oxidation of Trx (Fig. S4 in ESI†) as observed with NAP-SSH
(Fig. 1F).This journal is © The Royal Society of Chemistry 2016In cells, the disulde bond in the active site of Trx is reduced
by TrxR, which uses NADPH as an electron source. The catalytic
cycling of Trx between the oxidized and reduced states was
observed when 2 mM HSA-SSH was added to a solution con-
taining substoichiometric Trx (0.5 mM) in the presence of TrxR
and NADPH (0.007 and 250 mM), which led to a 95  3%
recovery of H2S from HSA-SSH (Fig. 2C).
We next assessed the kinetic parameters for the depersul-
dation of HSA-SSH by the Trx/TrxR system. The dependence of
the initial rate of NADPH consumption on the concentration of
HSA-SSH exhibited Michaelis–Menten-like kinetic behaviour
(Fig. 2D) yielding the apparent Km and Vmax parameters shown
in Table 1. The apparent kcat/Km value is similar to that reported
for insulin reduction by Trx,31 which is one of the best
substrates for the enzyme, indicating that the Trx/TrxR system
can also readily cleave protein persuldes.
A recent study indicated the existence of high levels of
intracellular and circulating LMW cysteine and glutathione
persuldes and suggested that uncatalyzed trans-persuldation
reactions between LMW persuldes and cysteine residues lead
to protein persuldation.32 This study also showed that the H2S-
producing enzymes, g-cystathionase (CSE) and cystathionine b-
synthase (CBS), produce large amounts of cysteine persulde
(Cys-SSH/Cys-SS) from cystine (CysSSCys) (Fig. 2E). We there-
fore tested the reactivity of Trx towards Cys-SSH. Recombinant
human CSE was incubated with CysSSCys at 37 C for 15 min
before separating the reaction mixture from the protein.
Approximately 50% of the substrate was converted to product
during this time as assessed using Ellman's reagent. Trans-
persuldation kinetics was initially monitored by spectro-
uorimetry31 measuring the tryptophan uorescence changes
caused by Trx oxidation (Fig. 2F). The dependence of the kobs of
the uorescence on the concentration of either CySSCys or the
CySSCys/CysSS mixture, yielded rate constants for the oxida-
tion of Trx by CySSCys and CysSS of 5  1  102 M1 s1 and
4.5  0.1  103 M1 s1, respectively (Table 1, Fig. S5 in ESI†).
When the Trx/TrxR/NADPH system was used, Michaelis–
Menten-like kinetic behaviour was observed (Fig. 2G) with the
CysSS/CysSSCys mixture yielding 2-fold higher Vmax than
CySSCys alone. Knowing the actual concentrations of both
CysSS and CysSSCys in the reaction mixture, we used
a competitive two-substrate equation33 to estimate the kinetic
parameters for CysSSH (Table 1). This analysis revealed that theChem. Sci., 2016, 7, 3414–3426 | 3417
Fig. 3 Improved tag-switch assay labels persulfides in cell lysates and fixed cells. (A) Original tag-switch assay with chemical structures of green
fluorescence cyanoacetic acid derivative, CN-BOT and cyanoacetic acid derivative, CN-Cy3. (B) Validation of CN-Cy3 labelling of protein
persulfides in tissue extracts fromCSE+/+ and CSE/mice (n¼ 3, *p < 0.01). Protein ladder in decreasing order: 245, 180, 135, 100, 75, 63, 48, 35,
25, and 20 kDa. (C) Validation of CN-BOT labelling of protein persulfidation in fixed cells. A decrease of intracellular persulfidation in SH-SY5Y
neuroblastoma cells could be observed after 1 h incubation with CBS inhibitor AOAA (2 mM). Incubation with 100 mMNa2S or 2 mM D-cysteine (1
h) leads to the increase of protein persulfidation. Semi-quantification of n ¼ 100 cells was performed using ImageJ software. Data represent
mean  S.E.M., *p < 0.01.
3418 | Chem. Sci., 2016, 7, 3414–3426 This journal is © The Royal Society of Chemistry 2016
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View Article Online
Fig. 4 Persulfidation co-localizes with mitochondria. (A) Co-locali-
zation studies of intracellular persulfidation. BAECs were transfected
with RFP fused to the leader sequence of E1 alpha pyruvate dehy-
drogenase and incubated with mitochondria-targeted H2S donor,
AP39. (B) SH-SY5Y neuroblastoma cells were transfected with
CellLight® Mitochondria-RFP, BacMam 2.0 to visualize mitochondria
and the cells were stained with improved tag-switch assay for per-
sulfidation. Analysis with ImageJ (version 1.45R) revealed that signifi-
cant co-localization was evident, which was visually represented as
white pixels using the co-localization highlighter. Mitochondria-tar-
geted H2S donor, AP39, lead to a strong increase in mitochondrial
persulfidation. Scale bar 10 mm. (C) 100 nM AP39 is much more
powerful inducer of persulfidation in the cells than 2 mM D-cysteine.
Scale bar 20 mm.
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View Article Onlinekcat/Km for CySS
 (3.9  105 M1 min1) is almost an order of
magnitude greater than for CysSSCys (0.5  105 M1 min1). It
is important to note that CysSSH, like NAP-SSH, is intrinsically
unstable in solution and it equilibrates to give a mixture of
cysteine polysuldes. Therefore, the kinetic values reported
here for CysSSH are likely to be an underestimation.This journal is © The Royal Society of Chemistry 2016One of the main problems for studying cellular persulda-
tion is the lack of selective tools for detecting protein persul-
des. Several methods have been described to date including
the tag-switch assay.7,13,25 This latter method is based on the
strategy of forming a mixed disulde using methylsulfonyl
benzothiazole (MSBT), an aromatic thiol-blocking reagent.25
The resulting mixed disulde is more reactive towards the
biotin-tagged cyanoacetic acid nucleophile than towards
cysteine disuldes present in proteins (Fig. 3A). The method
shows selectivity for persuldes without detectable cross-reac-
tivity with other post-translational modications of cysteine
that have been tested.25,26
The original assay used a biotinylated cyanoacetic acid tag,
which requires Western-blot transfer and streptavidin or anti-
bodies for visualization.25,26 To increase sensitivity, we synthe-
sized two new cyanoacetic acid derivatives with the uorescent
BODIPY moiety (CN-BOT) or the Cy3-dye (CN-Cy3) (Fig. 3A,
Scheme S1–S3 in ESI,† for details see Experimental section in
ESI†). Both new tags labelled HSA-SSH, yielding uorescent
products (Fig. S6 in ESI†). Preliminary studies using cell lysates
showed that the CN-Cy3 tag gave better resolution of labelled
bands and higher uorescence intensity than the CN-BOT tag.
However, when xed cells were used, CN-Cy3 proved difficult to
wash out (visible colouring of the washing solution was noticed
even 1 week aer washing). Therefore CN-BOT was used for
labelling cells for microscopy and CN-Cy3 for the labelling in
cell lysates.
The increase in sensitivity could be best illustrated by
comparing CN-Biotin with CN-Cy3 labelling, as shown in
Fig. S7 in ESI.† We used human erythrocytes and homoge-
nates of Drosophila melanogaster heads. Although persulda-
tion was detected by Western blot in the samples labelled by
CN-Biotin, stronger signals as well as higher numbers of
protein bands were detected in samples labelled by CN-Cy3,
demonstrating signicant improvement of the sensitivity
(Fig. S7 in ESI†).
Brain, heart, kidney and lung tissue extracts from 3C57BL/6
CSE+/+ and CSE/mice34 were also labelled with CN-Cy3. Lower
signal intensity indicative of lower total protein persuldation
was observed in all tissue extracts from CSE/mice conrming
the method's selectivity, with the effects being the strongest in
lungs and heart and only modest in brain, which is consistent
with the predominant roles of CBS and mercaptropyruvate
sulfur transferase (MST) in brain (Fig. 3B).
Protein persuldation in xed cells was visualized by
confocal microscopy using the tag-switch assay and the CN-BOT
reagent. As a negative control, cells were only treated with CN-
BOT without the initial MSBT blocking step, and as a positive
control, cells were pre-treated with H2S (1 h with 100 mM Na2S).
The signal intensity was barely detectable when CN-BOT was
used alone, and 20-fold greater laser intensity was needed to
observe a signal (Fig. S8A and B in ESI†). Treatment with Na2S
led to a substantial increase in uorescence intensity. Further
validation of the CN-BOT tag-switch assay was obtained from
experiments in which the CSE inhibitor propargylglycine (PG)25
and CBS inhibitor aminooxyacetic acid (AOAA) were used.35
Both inhibitors decreased the signal intensity in bovine arterialChem. Sci., 2016, 7, 3414–3426 | 3419
Fig. 5 Reaction of H2S with sulfenic acids and not with disulfides could be a mechanism for intracellular persulfidation. (A and B) Incubation of
SH-SY5Y neuroblastoma cells with 0.5 mM diamide (30 min) does not increase intracellular persulfidation, while the incubation with H2O2 (100
mM, 30 min) leads to a higher intracellular persulfide content (A). Treatment with 100 mM Na2S (1 h) was used as a positive control. At least 5
images were recorded from each experiment performed in triplicate. (B) Semi-quantification of 40 cells was performed using ImageJ software.
Data represent mean  S.E.M, *p < 0.01.
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View Article Onlineendothelial (BAE) and SH-SY5Y neuroblastoma cells (albeit not
completely), respectively (Fig. 3C and S8C in ESI†), while incu-
bation with Na2S or D-cysteine (an alternative substrate for MST-
catalyzed H2S generation)36 increased the uorescence signals.
These microscopy results were in good agreement with persul-
de analysis in cell lysates (Fig. S9 in ESI†).
To further validate the microscopy results, we transfected
mitochondria with RFP fused to the leader sequence of E1
alpha pyruvate dehydrogenase (CellLight®, Thermo Fischer
Scientic) and treated the cells with AP39, a novel mito-
chondria targeted H2S donor.37–39 Based on co-localization
studies, a signicant portion of persuldation appeared to be
localized in mitochondria in the presence or absence of 100
nM AP39 (Fig. 4A and B). AP39 induced a strong increase in
intracellular persuldation, 2-fold higher than observed
with 1 mM D-cysteine (Fig. 4C), suggesting that this
compound can be a powerful pharmacological tool for
modulating mitochondrial and intracellular H2S-mediated
persuldation.
H2S cannot react directly with cysteine thiols, and a plau-
sible mechanism for persulde formation is the reaction of
H2S with sulfenic acids or with disuldes.1,10 We recently
characterized the kinetics of these two reactions although
a priori, the reaction of H2S with disuldes is less likely to be
important in the cellular milieu, which is reducing.27 Cells
treated with H2O2 showed increased persuldation, relative to
control cells, and that could have been formed via either3420 | Chem. Sci., 2016, 7, 3414–3426mechanism (Fig. 5A and B). To distinguish between these
mechanistic possibilities, we treated cells with the thiol
oxidants, diamide (which induces disulde bond formation)
and H2O2 (which induces sulfenic acids in addition to disul-
des). While H2O2-treatment of SH-SY5Y cells resulted in
a signicant increase in uorescence intensity indicative of
protein persuldation, treatment with diamide led to a slight
decrease in intensity compared to untreated controls (Fig. 5A
and B), conrming that H2S-induced persulde formation
would be a consequence of its reaction with sulfenic acids and
not with protein disuldes.
During optimization of the labelling protocol, we observed that
persuldation levels in cell lysates obtained using native condi-
tions (HEN buffer pH 7.4, 1% protease inhibitor cocktail, 0 C),
decreased with incubation/extraction time (Fig. 6A and S10 in
ESI†). We hypothesized that the decrease in persuldation levels
could be due to the activity of the Trx/TrxR/NADPH system during
sample preparation. To test this hypothesis, we added 2 mM
auranon, an inhibitor of the Trx/TrxR/NADPH system,40–42 to the
native lysis buffer, which led to preservation of the persuldation
levels (Fig. 6A). Furthermore, addition of Trx/TrxR/NADPH to the
cell lysate led to immediate H2S release, as detected by the H2S
electrode (Fig. 6B).
Next, we assessed how inhibition of the Trx/TrxR system
affected intracellular protein persuldes levels. Cells (SH-SY5Y
and BAE) were treated with auranon (2 mM, 1 h) and then
labelled with CN-BOT. Incubation with auranon led to 1.8 This journal is © The Royal Society of Chemistry 2016
Fig. 6 Trx system is the main regulator of intracellular persulfide levels. (A) Due to the activity of Trx system in the cell lysates obtained under
native conditions (HEN buffer, pH 7.4, 1% protease inhibitors, 0 C), levels of persulfides detected by improved tag-switch assay decrease with the
time of protein extraction (gel on the left). This can be completely prevented by the addition of 2 mM auranofin into the lysis buffer (gel on the
right). Data are presented as mean  S.D (n ¼ 3), *p < 0.01. Protein ladder in decreasing order: 200 kDa, 150 kDa, 120 KDa, 100 kDa, 70 kDa, 60
kDa, 50 kDa, 40 kDa, 30 kDa, 25 kDa and 20 kDa. (B) Representative amperometric measurement of H2S release from BAEC lysate (1 mg mL
1
protein). Cell lysate was added first (first arrow), followed by the addition of a mixture containing 1 mM Trx, 0.01 mM TrxR and 250 mM NADPH
(second arrow). 100 mM ZnCl2 was added in the end to prove that the response is indeed from H2S. (C–E) Inhibition of Trx system with 2 mM
auranofin for 1 h, leads to an increase of intracellular persulfidation in BAE cells in a similar way like the treatment with 100 mM Na2S (1 h
incubation) as detected by fluorescence microscopy using CN-BOT based tag-switch assay (C) or measured in gel from the cell lysates, using
CN-Cy3 based tag-switch assay (D). Scale bar 20 mm. (E) Semi-quantification of in-gel fluorescence intensity. Experiments were performed in
triplicates. Data are presented as mean  S.D., *p < 0.01. (F–H) The effect of 2 mM auranofin or 100 mM Na2S treatments (1 h, 37 C) on the
intracellular persulfide levels in SH-SY5Y cells, measured by fluorescence microscopy using CN-BOT based tag-switch assay (F) or measured in
gel from the cell lysates, using CN-Cy3 based tag-switch assay (G). Scale bar 20 mm. (H) Semi-quantification of in-gel fluorescence intensity.
Experiments were performed in triplicates. Data are presented as mean  S.D., *p < 0.01.
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View Article Online0.2 (BAE cells) and 2.1  0.3 (SH-SY5Y cells) fold increases in
uorescence intensity (Fig. 6C and F) compared to control,
which was enhanced further by combining auranon with H2S.
An overall increase in intracellular persuldation was also
observed in cell lysates (Fig. 6D, E, G and H) and the quanti-
cation of in-gel uorescence signal matched nicely with the data
observed by uorescence microscopy.
Finally, we used an isotope dilution method mass spec-
trometry for quantication of the effect of auranon inhibition
of TrxR on intracellular persulde levels. This method is based
on the reaction of triphenylphosphines with sulfane sulfur
(Fig. S10 in ESI†).43 BAEC lysates were prepared with probe 1
being added directly to the lysis buffer together with probe 2
(Fig. S10 in ESI†). Following protein precipitation, acetonitrile
extracts were analysed by MS (Fig. S10 in ESI†). As observed
using the tag-switch assay, sulfane sulfur levels increased in
cells treated with auranon with a total value of 9  2 pmol
mg1 protein in control cells and 22  5 pmol mg1 protein in
auranon-treated cells (Fig. 7A).This journal is © The Royal Society of Chemistry 2016The increased Trx levels is associated with certain disease
states, such as rheumatoid arthritis, hepatitis C or HIV-1
infections.44–46 HIV-1 patients with high viral load have
increased levels of circulatory Trx.44,45 We used plasma
samples from HIV-1 patients with high viral load and
compared their sulfane sulfur levels with those from HIV-1
patients treated with antiretroviral therapy (ART) that contain
no detectable viral load. Signicantly lower total sulfane
sulfur levels were detected in patients with high viral load
(and therefore high circulatory Trx levels)44,45 compared to
ART-treated patients, conrming the role of Trx as a putative
depersuldase (Fig. 7B). Furthermore, there is a positive
correlation between the viral load and the level of circulatory
sulfane sulfur levels: the higher the viral load the lower the
sulfane sulfur levels (Fig. S11 in ESI†). Although the actual
role of lower persulde levels in those HIV-1 patients awaits
further investigation, this is the rst in vivo evidence that Trx
acts as depersuldase.Chem. Sci., 2016, 7, 3414–3426 | 3421
Fig. 7 In vitro and in vivo sulfane sulphur levels are control by thio-
redoxin system. (A) Quantification of total sulfane sulfur levels in
control and BAE cells treated with 2 mM auranofin for 1 h done by
isotope dilution MS approach (see Fig. S11 in ESI†). Data are presented
as mean values  S.D. of n ¼ 5, *p < 0.001. (B) Quantification of total
sulfane sulfur levels in plasma samples from untreated and ART-
treated HIV patients by isotope dilution MS approach. Data are pre-
sented as mean  S.D. *p < 0.001 (see Fig. S12 and Table S1†).
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View Article OnlineConclusion
In conclusion, our work identies Trx as a major regulator of
intracellular persuldation. Surprisingly, Trx showed almost an
order of magnitude higher reactivity towards persuldes than
towards disulde analogs. The high reactivity of Trx towards
LMW persuldes raises questions about the unusually high
levels of LMW persuldes (>100 mM) recently reported.32 The
identication of Trx as a depersuldase provides a new
perspective on persuldation as an oxPTM of cysteine by
revealing an enzymatic mechanism for reversing this post-
translational modication.
The improved tag-switch assay for facile persulde labelling
and subsequent in-gel detection or visualization by microscopy
led to the observation that a signicant portion of persulda-
tion is apparently localized in mitochondria. The use of the
mitochondria targeted H2S donor, or the MST substrate D-
cysteine, dramatically increased intracellular levels of persul-
dation implying an important role for MST and mitochondria-
derived H2S in protein persuldation. Under oxidative stress
conditions, formation of sulfenic acids is triggered which can
react with H2S to form protein persuldes. These conditions
also favour inhibition of the Trx system further prolonging the
half-life of protein persuldes. The actual consequences of3422 | Chem. Sci., 2016, 7, 3414–3426those steps remain to be elucidated. On one hand such
a mechanism could be protective, as overoxidized persuldated
cysteine residues (P-SSO3
2)23,25 could be reduced by Trx system
(similar like in the case of 30-phosphoadenosine-50-phospho-
sulfate reductase).47 Overoxidation of cysteine residues to form
P-SO3
2, however, remains irreversible. On the other hand,
excessive persuldation could be inhibitory for some enzymes
and prove detrimental in certain disease states. The improved
tag-switch method for persulde detection and herein reported
observation that Trx regulates persulde levels provide a good
starting point for the future studies which will answer those
questions and elucidate the actual mechanisms of H2S
signalling.
Materials and methods
Materials
All chemicals were purchased from Sigma Aldrich. All buffers
were prepared with nanopure water and treated with Chelex-100
resins to remove traces of metal ions. Na2S solutions were
prepared and handled as recommended.48 NAP-SSH was
prepared following the described synthetic protocol.30 (10-oxo-
10-(4-(3-thioxo-3H-1,2-dithiol-5-yl)phenoxy)decyl)triphenylphos-
phonium bromide (AP39) was synthesized in-house as
described.37
Ultra-high resolution mass spectrometry
Mass spectrometry was performed onmaXis 5G, Bruker Daltonik
(Bremen, Germany), an ESI-ToF MS capable of resolution of at
least 40.000 FWHM. Detection was in positive-ion mode. For the
real-timemeasurements, NAP-SSH and Trx weremixed fast in the
injection syringe (10 s) and then continuously injected into
maXis (150 mL h1). Spectra were recorded over 15 min time.
Measurements were performed under native conditions, i.e. only
in ammonium carbonate buffer pH 7.38. For the detection of Trx
oxidation, Trx solutions were incubated with NAP-SSH or HSA-
SSH for 2 min, mixed with acetonitrile (1 : 1, v/v) and formic acid
(0.1% nal concentration) and injected into MS.
Preparation of cysteine persulde
Recombinant human CSE (polymorphic variant S403) was
expressed and puried as described previously.49 Twenty mg of
CSE was added to 100 mM HEPES pH 7.4 containing 1 mM L-
cystine. The mixture was incubated at 37 C for 15 min and the
enzyme was separated by ultraltration (centrifugation at 14 000
 g at 4 C for 15 min) using a centrifugal lter with a molecular
weight cutoff of 10 kDa (Carl Roth, Karlsruhe, Germany). Cysteine
persulde in the ltrate was quantied with the DTNB method,
using an extinction coefficient 3412 of 14 150 M
1 cm1. Concen-
trations of remaining unreacted cystine were calculated accord-
ingly. Cysteine persulde solutions were used immediately aer
ltration and prepared freshly before each experiment.
Preparation of HSA-SSH
Persulde of human serum albumin was prepared and its
concentration quantied as reported previously.27This journal is © The Royal Society of Chemistry 2016
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View Article OnlineEnzyme kinetics of human Trx with cysteine persulde and
HSA-SSH
Kinetics of the reaction of human Trx with cysteine persulde was
performedmeasuring NADPH oxidation on HP 8452A diode array
spectrophotometer. As unreacted cystine could not be separated
from cysteine persulde, additional control measurements with
respective cystine concentrations under otherwise identical
conditions were performed. 1 mM human Trx, 10 nM TrxR and
250 mM NADPH were used in all measurements with various
concentrations of the substrates. The absorption maximum of
NADPH at 340 nm was monitored over a course of 5 min in
intervals of 5 s. The initial rate of A340 decrease was tted linearly
using Origin® analysis soware. Consumption of NADPH over
time was determined using an NADPH extinction coefficient 3340
of 6020M1 cm1. Rates of NADPH oxidation were plotted against
the concentration of themixture of cysteine persulde and cystine
or cystine alone, respectively. The data obtained were tted using
Michaelis–Menten equation in Origin® analysis soware. An
analogous set of experiments was performed using the persulde
derivative of HSA.Kinetics of the direct reaction of human Trx with cysteine
persulde and NAP-SSH
Kinetics of the reaction of thioredoxin with cysteine persude
was monitored on FP-8200 spectrouorometer (Jasco, Germany)
using an excitation wavelength of 280 nm and a maximal
emission of 345 nm. In two separate sets of experiments either
human or E. coli Trx (for comparison) were used. Concentration
of the enzyme was kept at 1 mM while substrate concentrations
ranged between 10 mM and 50 mM. Given pseudo rst-order
conditions, observed rate constants kobs were obtained by tting
the decrease in emission at 345 nm at a given cysteine persul-
de or cystine concentration using a rst order exponential
decay t in Origin® analysis soware. The kobs were plotted
against (CysSS + CysSSCys) or CysSSCys concentrations, and
linearized. For comparison, an analogous set of measurements
was performed using NAP-SSH and E. coli Trx.H2S detection
Kinetics of H2S release was followed amperometrically using
a selective H2S electrode connected to Free Radical Analyzer
(World Precision Instruments). Experiments were performed in
96-well plate in 200 mL volume. Electrode was calibrated using
standard Na2S solutions.Spectral characteristics of free and protein-bound uorescent
dyes
To compare spectral characteristics of free CN-BOT and free CN-
Cy3 with those of their HSA-bound counterparts, absorption and
emission spectra of those species were recorded. Namely, the
labelling was performed by blocking 200 mM HSA-SSH and 200
mMHSA-SH (as a control) with 10mMMSBT for 1 h at 37 C. Aer
purication from excess blocking reagent by methanol/chloro-
form precipitation, samples were split in two aliquots and treated
with 0.5 mM of CN-Cy3 and CN-BOT for 1 h at 37 C, respectively.This journal is © The Royal Society of Chemistry 2016Excess free dye was removed by three steps of ultraltration
(centrifugation at 14 000  g for 15 min) using a centrifugal lter
with a molecular weight cut-off of 3 kDa (Carl Roth, Karlsruhe,
Germany). For this, the solution, which was concentrated about
10-fold aer the individual centrifugation steps, was diluted to its
original volume and the centrifugation was repeated. Aer the last
centrifugation step, a methanol/chloroform precipitation was
performed and the obtained protein pellets were re-dissolved in
PBS. Absorption spectra were recorded at a HP 8452A diode array
spectrophotometer, and uorescence spectra were at a FP-8200
spectrophotometer (Jasco, Germany).
Cell culture
SH-SY5Y cells (ECACC, Sigma Aldrich) were grown in Ham's
F12 : DMEM (1 : 1) medium supplemented with 2 mM gluta-
mine, 1% non-essential amino acids, and 10% fetal bovine
serum at 37 C and 5% CO2. BAE cells were grown in Ham's F12
medium supplemented with 2mM glutamine, 1% non-essential
amino acids, and 10% fetal bovine serum at 37 C and 5% CO2.
Mice
CSE+/ and CSE/mice were generated and characterized earlier
(Ishii et al., 2010). In this study, CSE+/ males and females were
bred to obtain CSE+/+, CSE+/ and CSE/ littermates. The Berlin
Animal Review Board approved all protocols that were conducted
to American Physiological Society standards.
CN-Cy3-based detection of persulde levels in CSE/ and
CSE+/+ mice
Organs (lungs, kidney, heart, liver, and brain) from CSE/ and
CSE+/+ mice were isolated on ice, cleaned from connective
tissue, and washed with ice-cold PBS. Immediately aer isola-
tion, the tissue was minced and homogenized on ice in HEN
buffer (100 mM HEPES, 1 mM EDTA, 0.1 mM neocuproine, 1%
SDS, pH7.4) supplemented with 20 mM MSBTA, 1% NP40 and
1% protease inhibitor cocktail, using Potter homogenizer.
Homogenates were centrifuged at 10 000  g for 20 min at 4 C
and clear supernatant was further incubated on ice for 1 h. 200
mL of supernatant samples were precipitated with water/meth-
anol/chloroform mixture (v/v/v: 4/4/1) and centrifuged at 14 000
 g for 20 min at 4 C. Obtained protein precipitates were dried
under vacuum at 4 C and stored at 80 C. For improved tag-
switch assay equal amounts of sample proteins (50 mg) were
incubated with 100 mM Cy3-CN in 50 mM HEPES (pH 7.4)
supplemented with 1.5% SDS, in dark, at 37 C for 2 h, mixed
with 4 non-reducing sample buffer (Bio-Rad, USA) and incu-
bated for 30min at 50 C in dark. Samples were resolved on 10%
SDS polyacrylamide gels in dark and immediately aer short
xation and washing gels were scanned using ChemiDoc MP
uorescent imager (Bio-Rad, USA). Obtained images were semi-
quantied using ImageJ soware (NIH, USA).
In situ uorescence detection of intracellular persuldation
Cells were grown in m-dishes (35 mm, high) obtained from
Ibidi® following manufacturer's instructions. The treatmentsChem. Sci., 2016, 7, 3414–3426 | 3423
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View Article Onlinewith inhibitors, Na2S and AP39 were performed over 1 h. Aer
treatments the cells were washed twice with warm sterile PBS.
Fixation was carried out by incubation with ice-coldmethanol at
30 C for 20 min and subsequent permeabilization with ice-
cold acetone at 30 C for 5 min. The dishes were washed with
PBS and incubated with 50 mM HEPES containing Triton (1%)
and MSBT (10 mM) at RT overnight. Aer 3 washing the cells
with PBS they were incubated with CN-BOT (25 mM) in PBS for 1
h at 37 C. The cells were then washed 5 with PBS and stained
with DAPI following manufacturer's recommendation. Images
of 1024  1024 pixels were obtained using a LSM 780 confocal
laser scanning system (Carl Zeiss MicroImaging) equipped with
an Argon laser (458, 488, and 514 nm), a diode laser (405 nm),
a DPSS-laser (561 nm) (LASOS Lasertechnik, Jena, Germany),
mounted on an inverted Axio Observer Z1. The lter settings of
the confocal scanner were: 514 nm excitation for Cy3 (MBS 458/
561, lter 566–681 nm), 488 nm excitation for Alexa 488 (MBS
488/561/633, lter 493–543 nm) and 405 nm excitation for 40,6-
diamidino-2-phenylindole hydro-chloride (MBS-405). A 20 dry
objective lens (numerical aperture 0.8) and a 63 oil objective
lens (numerical aperture 1.4) were used. Sequential scanning
and appropriate pinhole settings minimized spectral bleed-
through. For examination of co-localization of immunouo-
rescence, single optical sections at the same focus plane were
taken separately and the three corresponding channels were
merged into a 8-bit RGB tiff-le using confocal assistant so-
ware ZEN 2010.
Mitochondrial visualization and co-localization studies
For co-localization studies, cells were transfected with
CellLight® Mitochondria-RFP, BacMam 2.0 obtained from
ThermoFisher Scientic® following the manufacturer's
instructions. It is a fusion construct of the leader sequence of E1
alpha pyruvate dehydrogenase and TagRFP, providing specic
targeting of cellular mitochondria-RFP through transient
transfection with the insect virus baculovirus. Aer transfection
and following the expression of mitochondria-RFP overnight,
the cells were treated with AP39, D-Cys and auranon for 1 h at
37 C. Cells were xed with 4% formaldehyde for 45 min,
washed with PBS and incubated with 50 mM HEPES containing
Triton (1%) and MSBT (10 mM) at room temperature overnight.
Aer washing with PBS (3), the xed cells were incubated with
CN-BOT (25 mM) in PBS for 1 h at 37 C. The cells were then
washed 5 with PBS and stained with DAPI following manu-
facturer's recommendation.
Detection of protein persuldation in cell lysates
Cells were grown in T-75 cell culture asks. Aer treatments, the
cells were washed twice with warm sterile PBS. Lysis was per-
formed by addition of 800 mL HEN buffer (50 mM HEPES, 0.1
mM EDTA, pH 7.4) containing SDS (1.5%), NP-40 (1%), protease
inhibitor cocktail (1%) and MSBT (10 mM) to a T-75 ask. Cells
were incubated for 10min on ice with occasional scraping of the
ask surface with a cell scraper. The lysates were transferred to
microcentrifugation tubes and incubated at 37 C for 1 h.
Protein precipitation was performed using H2O/CHCl3/MeOH3424 | Chem. Sci., 2016, 7, 3414–3426(4/1/4) precipitation, with subsequent vigorous mixing and
centrifugation (20 000  g, 20 min, 4 C). The supernatant was
discarded and the precipitate was dried. The pellet was resus-
pended in 300 mL of 50 mM HEPES containing 3% SDS. Lysates
were stained with CN-Cy3 (60 mM) for 1 h at 37 C. SDS-PAGE
was run under non-reducing conditions and the gels were
recorded on a ChemiDocTM MP System with the Cy3 setup.Isotope dilution mass spectrometry for the quantication of
sulfane sulfur
The reagents were synthesized as described previously.40 1 mM
probe 1 and 30 mM probe 2 (nal concentrations) were added
into the HEN lysis buffer which also contained 1.5% SDS and
1% protease inhibitors. 200 mL of this mixture was added
directly into the ask and cells scraped from the ask. Cell
lysates were then incubated 1 h at 37 C with occasional
vigorous vortexing. Protein concentrations were determined in
the samples and proteins were then precipitated by the addition
of acidied acetonitrile. Samples were vortexed and centrifuged,
and the supernatants were taken for the MS analysis.HIV patients
11 HIV-1-infected patients were included in the study. The study
was approved by the Ethics Committee of the Medical Faculty of
the Friedrich-Alexander-Universita¨t Erlangen-Nu¨rnberg and the
patients gave informed consent. The patient characteristics are
shown in the Table S1.† Five patients were on antiretroviral
treatment with a suppressed viral load of <20 copies per ml and
amedian CD4 count of 364/ml (range 309–955). Six patients were
untreated with a median HIV-1-viremia of 10 700 copies per ml
(range 2600–5 400 000) and a median CD4 count of 436 (range
143–684). Sulfane sulfur levels were expressed as pmol mg1 of
plasma protein.Conflict of interest
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